WCN 2019

INDUSTRY SYMPOSIUM PROGRAMS


SUNDAY, OCTOBER 27 2019

NMOSD AND MS: TIME TO SHIFT OUR FOCUS 

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY roclogo_rgb_72_36.jpg

CHAIR: Bassem Yamout, Lebanon

Sunday, October 27 | 13:00 - 14:30 | Sheikh Rashid A 

13:00-13:05      Welcome and Introduction 
Bassem Yamout, Lebanon

13:05-13:35       NMOSD : A journey from pathogenesis to diagnosis 
                             Brian Weinshenker, USA  

13:35-13:55       Disease progression : Changing how we think about MS 
                             Xavier Montalban, Canada

13:55-14:20      Ocrelizumab : Growing evidence from clinical trials on longer term outcomes  
Bassem Yamout, Lebanon

14:20-14:30       Q&A and closing remarks
                             All faculty

     

MONDAY, OCTOBER 28 2019

THE EVOLVING MANAGEMENT OF PATIENTS WITH EARLY AND LATER-ONSET SMA

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Biogen.png

CHAIR: Waseem Fathalla, UAE

Monday, October 28 | 13:00 - 14:30 | Sheikh Rashid A 

13:00–13:05      Welcome and introduction
                             Waseem Fathalla, UAE

13:05–13:20      Recognizing the patient with SMA
                            Eugenio Mercuri, Italy

13:20–13:40      Experience of managing patients with early and later-onset SMA with nusinersen
                            Francesco Muntoni, UK

13:40–14:00      Managing the adult patient with SMA: setting treatment expectations in the real world
Albert Ludolph, Germany

14:00–14:20      Real-world experience of managing SMA in the UAE: practical experience and challenges
Waseem Fathalla, UAE

14:20–14:30      Discussion and Q&A
                             All faculty


TACKLING THE GLOBAL BURDEN OF MIGRAINE: CGRP AND EMERGING THERAPIES

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY tEVA.jpg
CHAIR: Vera Osipova, Russia

Monday, October 28| 13:00-14:30 | Sheikh Rashid B

13:00-13:10       Welcome and Introductions
                             Vera Osipova, Russia

13:10-13:30       Global Burden and Impact of Migraine
                             Abouch Valenty Krymchantowski, Brazil

13:30-13:50       CGRP Peptide and Its Role in Pain and Migraine
                            Anthony Dickenson, England

13:50-14:10       Migraine Prevention: Data on Anti-CGRP Monoclonal Antibodies
                             Richard J. Stark, Australia

14:10-14:30       Panel Discussion: Questions and Answers
                             Moderated by Vera Osipova, Russia


TUESDAY, OCTOBER 29 2019

GENE THERAPY FOR SPINAL MUSCULAR ATROPHY: TRANSLATING RESEARCH INTO REALITY

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY AveXis.png

CHAIR: Abdulaziz Saeid Al-Saman, Saudi Arabia

Tuesday, October 29| 13:00-14:30 | Sheikh Rashid A

13:00-13:10        Welcome and introduction
                              Abdulaziz Saeid Al-Saman, Saudi Arabia

13:10-13:25        Overview of spinal muscular atrophy (SMA) clinical course
                              Fouad Al-Ghamdi, Saudi Arabia

13:25-13:55        Delivering cutting-edge gene therapy for SMA
                              Samiah Al-Zaidy, USA

13:55-14:15        Practical aspects of gene therapy including biosafety
                              Daniel Gibbs, USA

14:15-14:25         Panel discussion
                              All Speakers

14:25-14:30         Symposium close
                              Abdulaziz Saeid Al-Saman, Saudi Arabia

---------------------------------------------------------------------------------------------------------------------